Código QR (código de barras bidimensional)

Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

The introduction of immune checkpoint inhibitors (ICI) has revolutionized the treatment of many solid tumors including advanced non-small cell lung cancer (NSCLC) without targetable driver alterations. Unfortunately, the majority of patients with NSCLC do not respond to ICI treatment or will eventua...

ver descrição completa

Na minha lista:

Detalhes bibliográficos
Principais autores:	John B A G Haanen, Daniel S Peeper, Egbert F Smit, Willemijn S M E Theelen, Daphne Van der Geest, Alex van Vliet
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2025-11-01
coleção:	Journal for ImmunoTherapy of Cancer
Acesso em linha:	https://jitc.bmj.com/content/13/11/e013110.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

Registros relacionados